co-infections

People's Country Operational Plan on HIV and TB (People's COP19)

With only a year until 2020 – and the deadline to reach the 90-90-90 targets – South Africa is dangerously off track. Currently 7.1 million people are living with HIV in the country. New HIV infections remain high, according to the Thembisa model1 at 275 000 in 2017, higher than the 231 000 estimated in the Human Sciences Research Council (HSRC) survey.

Include in home page features rotation
Off

Conference on Retroviruses and Opportunistic Infections (CROI 2019)

Venue
Seattle, Washington, USA

The annual Conference on Retroviruses and Opportunistic Infections (CROI) brings together top basic, translational, and clinical researchers from around the world to share the latest studies, important developments, and best research methods in the ongoing battle against HIV/AIDS and related infectious diseases. CROI 2019 will be held from March 4 to March 7, 2019, at the Washington State Convention Center in Seattle, Washington.

Include in home page features rotation
Off

Associated factors with unsuccessful tuberculosis treatment outcomes among tuberculosis/HIV coinfected patients with drug-resistant tuberculosis

Author
Azeez, A., et al.

BACKGROUND: In Sub-Saharan Africa, HIV endemic has substantially contributed to the increasing tuberculosis (TB) incidence. The joint effect of the HIV and TB pestilences has confronted the feeble systems of healthcare in resource-limited countries.

Include in home page features rotation
Off

9th SA AIDS Conference 2019

Venue
Durban, South Africa
The 9th South African AIDS Conference will focus on scientific, social and digital innovations which could expand possibilities and opportunities towards controlling the HIV & AIDS epidemic. The conference will determine how contemporary explosive and disruptive technologies will contribute towards sustained HIV prevention efforts, HIV testing, ART uptake and adherence, trigger the development of new drugs, effectively utilise enormous volumes of data and improve communication and service delivery and eventually end the epidemic.
Include in home page features rotation
Off

INTEREST - 13th International Conference on HIV Treatment, Pathogenesis, and Prevention Research in Resource-Limited Settings

Venue
Accra, Ghana

Known as the “African CROI” the INTEREST Conference brings together scientists involved in HIV treatment, pathogenesis, and prevention research in Africa to share pivotal findings, promote collaboration, and transfer experiences across several fields and many continents. The conference will showcase cutting-edge knowledge in the diagnosis and treatment of HIV and the prevention of the HIV-1 infection.

Include in home page features rotation
Off

Treating key and mobile populations as people, not public health problems

Of no surprise to those in the HIV field, the epidemic continues to be fueled by stigma, none more evident than among key and mobile populations, such as people who inject drugs and sex workers. Speakers at the Southern African HIV Clinicians Society conference shared their experiences in working with these groups and challenged participants to view them as people – and not merely a public health problem.  
Author
SHARE staff

AIDS 2018: Finding ways to break barriers and build bridges to improve HIV prevention, care, and treatment

People infected and affected by HIV face multiple, far-reaching barriers every day – from structural barriers affecting their access to services and care, to societal and scientific barriers keeping them from enjoying healthy, safe, and full lives. We highlight some of these barriers, and what innovative approaches are being developed to bridge them.
Author
SHARE staff

HIV and hepatitis B and C co-infection among people who inject drugs in Zanzibar

Is the resource available on the Internet?
Yes
Author
Khatib A, Matiko E, Khalid F, Welty S, Ali A, Othman A, Haji S, Dahoma M, Rutherford G

People who inject drugs are at high risk of acquiring hepatitis B (HBV), hepatitis C (HCV), and human immunodeficiency virus (HIV) due to risky injection and sexual practices. The objective of this study is to investigate the epidemiology of HIV, hepatitis B, and hepatitis C, and co-infection of these viruses among people who inject drugs in Zanzibar, Tanzania.

Include in home page features rotation
Off
Subscribe to co-infections